Jump to content

Draft:Kevin A. Giraldo

From Wikipedia, the free encyclopedia

Kevin A. Giraldo is a Colombian engineer and scientist working at the forefront of AI-powered nucleic acid-based technologies for therapeutics and biosensing. He is known for his contributions to biosensor development, microfluidics, and machine-learning applications in healthcare[1].

He studied at the Universidad de Los Andes, where he graduated bachelor's degree in Biomedical Engineering. He subsequently pursued a master's degree specialising in Biomaterials and Tissue Engineering at Imperial College London. Under the mentorship of Prof. Dame Molly Stevens, he developed a sensor for studying insulin release from pancreatic islets in organ-on-chip technologies for drug development [2].

Kevin A. Giraldo
NationalityColombian
Alma materUniversidad de Los Andes (BSc)
Imperial College London (MSc)
Scientific career
InstitutionsUniversity of Oxford
Academic advisorsProf. Dame Molly Stevens, Prof. Juan C. Cruz [3]




References

[edit]
  1. ^ "Kevin A. Giraldo". scholar.google.com. Retrieved 2024-12-07.
  2. ^ "Meet the Team". The Stevens Group. Retrieved 2024-12-07.
  3. ^ "Biotecnología y Biomateriales". 24 October 2019.